These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20193849)

  • 21. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
    Courjal F; Theillet C
    Cancer Res; 1997 Oct; 57(19):4368-77. PubMed ID: 9331100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
    Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
    Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haplo-insufficiency of BRCA1 in sporadic breast cancer.
    Staff S; Isola J; Tanner M
    Cancer Res; 2003 Aug; 63(16):4978-83. PubMed ID: 12941823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholinesterase activity of human lung tumours varies according to their histological classification.
    Martínez-Moreno P; Nieto-Cerón S; Torres-Lanzas J; Ruiz-Espejo F; Tovar-Zapata I; Martínez-Hernández P; Rodríguez-López JN; Vidal CJ; Cabezas-Herrera J
    Carcinogenesis; 2006 Mar; 27(3):429-36. PubMed ID: 16272577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.
    Bièche I; Tomasetto C; Régnier CH; Moog-Lutz C; Rio MC; Lidereau R
    Cancer Res; 1996 Sep; 56(17):3886-90. PubMed ID: 8752152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic alterations in ERBB2-amplified breast carcinomas.
    Isola J; Chu L; DeVries S; Matsumura K; Chew K; Ljung BM; Waldman FM
    Clin Cancer Res; 1999 Dec; 5(12):4140-5. PubMed ID: 10632352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer.
    Park K; Han S; Gwak GH; Kim HJ; Kim J; Kim KM
    Breast Cancer Res Treat; 2006 Aug; 98(3):337-42. PubMed ID: 16502015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.
    Bièche I; Lidereau R
    Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo gene amplification in non-cancerous cells: cholinesterase genes and oncogenes amplify in thrombocytopenia associated with lupus erythematosus.
    Zakut H; Lapidot-Lifson Y; Beeri R; Ballin A; Soreq H
    Mutat Res; 1992 May; 276(3):275-84. PubMed ID: 1374519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
    Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
    Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401.
    ; Tanner M; Isola J; Wiklund T; Erikstein B; Kellokumpu-Lehtinen P; Malmström P; Wilking N; Nilsson J; Bergh J
    J Clin Oncol; 2006 Jun; 24(16):2428-36. PubMed ID: 16682728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of HER-2/neu/c-erbB-2 gene amplification in benign and malignant breast disease.
    Supanaranond K; Sukarayodhin S; Tanyakaset M; Balachandra K; Jullaksorn D; Rienkijkarn M; Hoisanka N; Tantivanich S
    Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):631-40. PubMed ID: 9561622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of methods used for the determination of cholinesterase activity in whole blood.
    Naik RS; Doctor BP; Saxena A
    Chem Biol Interact; 2008 Sep; 175(1-3):298-302. PubMed ID: 18555980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneous gene alterations in primary breast cancer contribute to discordance between primary and asynchronous metastatic/recurrent sites: HER2 gene amplification and p53 mutation.
    Sekido Y; Umemura S; Takekoshi S; Suzuki Y; Tokuda Y; Tajima T; Osamura RY
    Int J Oncol; 2003 Jun; 22(6):1225-32. PubMed ID: 12738987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ErbB-2 expression and its association with other biological parameters of breast cancer among Indian women.
    Vaidyanathan K; Kumar P; Reddy CO; Deshmane V; Somasundaram K; Mukherjee G
    Indian J Cancer; 2010; 47(1):8-15. PubMed ID: 20071783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer.
    Orlando L; Del Curto B; Gandini S; Ghisini R; Pietri E; Torrisi R; Balduzzi A; Cardillo A; Dellapasqua S; Veronesi P; Viale G; Goldhirsch A; Colleoni M
    Breast; 2008 Oct; 17(5):506-11. PubMed ID: 18456496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer.
    Iacopetta B; Grieu F; Powell B; Soong R; McCaul K; Seshadri R
    Clin Cancer Res; 1998 Jul; 4(7):1597-602. PubMed ID: 9676832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.